UBS Group’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-49,100
Closed -$3.19M – 9991
2024
Q3
$3.19M Buy
+49,100
New +$3.15M ﹤0.01% 3525
2020
Q4
– Sell
-24,600
Closed -$2.13M – 8433
2020
Q3
$2.13M Buy
+24,600
New +$2.05M ﹤0.01% 2983
2018
Q3
– Sell
-17,000
Closed -$1.84M – 8009
2018
Q2
$1.84M Buy
+17,000
New +$1.83M ﹤0.01% 3250
2017
Q3
– Sell
-20,500
Closed -$1.82M – 7748
2017
Q2
$1.82M Buy
+20,500
New +$1.8M ﹤0.01% 3098
2014
Q3
– Sell
-300
Closed -$21K – 10403
2014
Q2
$21K Buy
+300
New +$21.8K ﹤0.01% 8004

Other funds holding CRI

UBS Group's CRI Position: Q3 2026 in Review

UBS Group increased its Carter's (CRI) stake by 37% in Q3 2026, buying an estimated $9.17M and bringing the position to 943,534 shares worth $29.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2230.

UBS Group first reported a position in CRI in Q2 2013 and has held it in 54 quarters since. The position peaked at $87.5M in Q4 2024. 295 funds tracked by Wall St. Rank hold CRI as of Q3 2026.

  • UBS Group held 943,534 shares of Carter's worth $29.5M as of Q3 2026.
  • UBS Group bought 256,554 Carter's shares in Q3 2026, an estimated $9.17M.
  • Carter's made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #2230 holding.
  • UBS Group first reported a position in Carter's in Q2 2013 and has held it in 54 quarters since.
  • UBS Group's Carter's position peaked at $87.5M in Q4 2024.
  • 295 funds tracked by Wall St. Rank held Carter's as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.